Coronavirus Disease 2019 Treatment—T-Cells Hold the Key in Severe Cases

Kunal Das; Nitika Agrawal; Mansi Kala; Rakhee Khanduri

doi:10.1055/s-0041-1729343

Indian Journal of Medical and Paediatric Oncology, Table of Contents

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2021; 42(01): 003-005
DOI: 10.1055/s-0041-1729343

Editorial

Coronavirus Disease 2019 Treatment—T-Cells Hold the Key in Severe Cases

Authors

Kunal Das

¹Department of Pediatrics, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India
Nitika Agrawal

¹Department of Pediatrics, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India
Mansi Kala

²Department of Pathology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India
Rakhee Khanduri

³Department of Pulmonary Medicine, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India

Abstract

Full Text

References

References
1 Sohrabi C, Alsafi Z, O’Neill N. et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71-76
2 Lu R, Zhao X, Li J. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395 (10/224) 565-574
3 World Health Organization. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19; June 22, 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-fhe-media-briefing-on-covid-19—22-june-2020. Accessed April 8, 2021
4 Barro R, Ursua J, Weng J. The Coronavirus and the Great Influenza Pandemic: Lessons from the ‘Spanish Flu’ for the Coronavirus’ Potential Effects on Mortality and Economic Activity. NBER Working Paper, No 26866; 2020
5 Vaduganathan M, Vardeny O, Michel T, McMurray JJ, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med 2020; 382 (17) 1653-1659
6 Kuba K, Imai Y, Rao S. et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 2005; 11 (08) 875-879
7 Transmission of SARS-CoV-2: Implications for infection prevention precautions. Updated; July 9, 2020. Available from: https://www.who.int/publications/i/item/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations. Accessed April 8, 2021
8 Xu Z, Shi L, Wang Y. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8 (04) 420-422
9 Wan S, Yi Q, Fan S, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel Coronavirus pneumonia (NCP). medRxiv 2020;02.10.20021832 [doi: 10.1101/2020.02.10.20021832].
10 Tan L, Wang Q, Zhang D. et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther 2020; 5 (01) 33
11 Debliquis A, Harzallah I, Mootien JY. et al. Haemophagocytosis in bone marrow aspirates in patients with COVID-19. Br J Haematol 2020; 190 (02) e70-e73
12 Carsana L, Sonzogni A, Nasr A. et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis 2020; 20 (10) 1135-1140
13 Diao B, Wang C, Tan Y. et al. Reduction and functional exhaustion of T Cells in patients with Coronavirus disease 2019 (COVID-19). Front Immunol 2020; 11: 827
14 Ing EB, Xu QA, Salimi A, Torun N. Physician deaths from corona virus (COVID-19) disease. Occup Med (Lond) 2020; 70 (05) 370-374
15 Pujadas E, Chaudhry F, McBride R. et al. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med 2020; 8 (09) e70
16 Geleris J, Sun Y, Platt J. et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 2020; 382 (25) 2411-2418
17 Gautret P, Lagier JC, Parola P. et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020; 56 (01) 105949
18 Dexamethasone in hospitalized patients with Covid-19 — preliminary report. N Engl J Med. 2020. DOI:10.1056/NEJMoa 2021436
19 Luznik L, O’Donnell PV, Fuchs EJ. Post-transplantation cyclop-hosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. Semin Oncol 2012; 39 (06) 683-693
20 Willicombe M, Thomas D, McAdoo S. COVID-19 and calcineurin inhibitors: Should they get left out in the storm?. J Am Soc Nephrol 2020; 31 (06) 1145-1146
21 Guaraldi G, Meschiari M, Cozzi-Lepri A. et al. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol 2020; 2 (08) e474-e484
22 Arabi YM, Mandourah Y, Al-Hameed F. et al. Saudi Critical Care Trial Group. Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med 2018; 197 (06) 757-767
23 Song JW, Zhang C, Fan X. et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun 2020; 11 (01) 3410
24 Zeng F, Huang Y, Guo Y. et al. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis 2020; 96: 467-474
25 Velavan TP, Meyer CG. Mild versus severe COVID-19: laboratory markers. Int J Infect Dis 2020; 95: 304-307
26 Gao Y, Li T, Han M. et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol 2020; 92 (07) 791-796
27 Grein J, Ohmagari N, Shin D. et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med 2020; 382 (24) 2327-2336
28 Şimşek Yavuz S, Ünal S. Antiviral treatment of COVID-19. Turk J Med Sci 2020; 50 (Suppl. 01) 611-619
29 Revannasiddaiah S, Kumar Devadas S, Palassery R, Kumar Pant N, Maka VV. A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2. Med Hypotheses 2020; 144: 109850
30 Rico-Mesa JS, Rosas D, Ahmadian-Tehrani A, White A, Anderson AS, Chilton R. The role of anticoagulation in COVID-19-induced hypercoagulability. Curr Cardiol Rep 2020; 22 (07) 53
31 Malani AN, Sherbeck JP, Malani PN. Convalescent plasma and COVID-19. JAMA 2020; 324 (05) 524